GO:2000767 positive regulation of cytoplasmic translation: Protein Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000767 (positive regulation of cytoplasmic translation) describes any process that activates or increases the frequency, rate or extent of cytoplasmic translation, the ribosome-driven synthesis of proteins in the cytoplasm.
• Cytoplasmic translation is positively regulated by nutrient and growth-factor signaling through mTOR-dependent control of translation factors, by ribosome-associated factors such as the P-stalk, and by RNA-binding proteins that alter mRNA stability or translation efficiency.
• Dysregulated positive regulation of cytoplasmic translation drives cancer growth, T cell dysfunction in tumors, and metabolic reprogramming of cancer cells [1,2,4,5].
• Viruses, including alphaviruses and coronaviruses, hijack host cytoplasmic translation and its positive regulators to favor viral protein synthesis [3,8].
• Key experimental approaches to study this process include ribosome profiling (Ribo-seq), polysome profiling, RNA-seq, proteomics, and imaging of nascent peptides.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of candidate positive regulators of cytoplasmic translation.
Description
GO:2000767, positive regulation of cytoplasmic translation, is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of cytoplasmic translation. Cytoplasmic translation is the ribosome-dependent synthesis of polypeptides from cytoplasmic mRNAs, and its positive regulation is essential for cell growth, proliferation, and rapid responses to nutrients and stress. Because translation consumes a large fraction of cellular energy, its positive regulators are tightly controlled and are frequently co-opted in disease [6,7]. Understanding how this process is activated is therefore central to basic cell biology and to translational medicine. Recent studies show that positive regulators of cytoplasmic translation can be hijacked in cancer to promote oncogenic protein synthesis and immune evasion [1,2,4,5]. For example, the RNA-binding protein LARP4 mediates hypertranslation that drives T cell dysfunction in tumors, and the ubiquitin ligase KLHL6 modulates resistance to CD8+ T cell dysfunction. In hepatocellular carcinoma, RIOK1 phase separation restricts PTEN translation via stress granules, illustrating how positive and negative inputs converge on cytoplasmic translation to shape tumor growth. Viral pathogens also exploit positive regulation of cytoplasmic translation: alphaviruses and coronaviruses reprogram host translation machinery to favor viral protein synthesis [3,8]. This article integrates the QuickGO definition with verified PubMed literature to summarize the mechanisms, key genes, disease links, and research methods relevant to GO:2000767.
positive regulation of cytoplasmic translation At A Glance
| GO ID | GO:2000767 |
|---|---|
| GO term | positive regulation of cytoplasmic translation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Activates or increases the frequency, rate or extent of cytoplasmic translation |
| Parent term | regulation of cytoplasmic translation |
| Related processes | Translation, regulation of translation, cytoplasmic translation |
| Key regulators | mTOR signaling, translation initiation factors, RNA-binding proteins, ribosome-associated factors |
| Disease relevance | Cancer, T cell dysfunction, viral infection, metabolic disorders |
What Is GO:2000767?
In our own words, GO:2000767 refers to any biological process that increases the activity of cytoplasmic translation. Cytoplasmic translation is the process in which ribosomes in the cytoplasm decode messenger RNAs (mRNAs) into proteins. Positive regulation can occur at multiple levels: increasing the availability or activity of translation initiation factors, enhancing ribosome recruitment to mRNAs, promoting elongation or termination, or stabilizing translating mRNAs. The term is a child of the broader regulation of cytoplasmic translation and is distinct from transcriptional or nuclear events. It encompasses signaling pathways (e.g., mTOR), RNA-binding proteins, ribosome-associated factors, and viral or cellular factors that collectively raise the rate of protein synthesis in the cytoplasm [6,7].
Why Is positive regulation of cytoplasmic translation Important in Cell Biology?
Positive regulation of cytoplasmic translation is important because it controls the rate of protein synthesis, which directly influences cell growth, proliferation, differentiation, and survival. Dysregulation of this process is a hallmark of many cancers, where oncogenic signaling drives hypertranslation to support rapid tumor growth and immune evasion [1,2,4,5]. It is also critical for immune cell function, as excessive translation in T cells can lead to dysfunction in the tumor microenvironment. Moreover, viruses such as alphaviruses and coronaviruses hijack positive regulators of cytoplasmic translation to produce viral proteins efficiently [3,8]. Understanding GO:2000767 therefore provides insights into fundamental cell biology and offers therapeutic targets for cancer, infectious diseases, and immune disorders.
• Controls the rate of protein synthesis, a fundamental determinant of cell growth and proliferation.
• Drives oncogenic protein synthesis in cancers such as hepatocellular carcinoma and liver cancer [2,4].
• Mediates T cell dysfunction and resistance to immunotherapy in tumors [1,5].
• Is exploited by viruses (alphaviruses, coronaviruses) to favor viral protein production [3,8].
• Integrates nutrient and growth factor signals via mTOR and translation factors.
• Involves ribosome-associated factors such as the P-stalk that regulate cytokine-mediated processes.
• Represents a target for therapeutic intervention in cancer and viral infections [3,4,5].
• Can be studied with CRISPR screens to identify novel positive regulators [1,5].
• Links metabolism, stress responses, and translation control [4,6].
• Provides mechanistic insights into immune cell engineering and immunotherapy [1,5].
What Happens During positive regulation of cytoplasmic translation?
Initiation of translation is enhanced
In simple terms: The cell boosts the first step of protein synthesis, where ribosomes attach to mRNA.
Positive regulation of cytoplasmic translation often begins with increased translation initiation. Nutrients and growth factors activate mTOR signaling, which promotes the assembly of the eIF4F complex and the recruitment of ribosomes to mRNAs. This step is rate-limiting for most mRNAs and is a major target of positive regulators. For example, LARP4-mediated hypertranslation in T cells involves enhanced initiation on specific mRNAs.
Elongation and termination are accelerated
In simple terms: After initiation, the ribosome moves faster along the mRNA and finishes protein synthesis more efficiently.
Positive regulation can also act at elongation and termination. Ribosome-associated factors such as the P-stalk are master regulators of cytokine-mediated processes and can influence the efficiency of elongation and termination. In hepatocellular carcinoma, RIOK1 phase separation restricts PTEN translation via stress granules, showing that elongation and termination can be modulated by phase-separated compartments.
mRNA stability and availability are increased
In simple terms: The cell makes mRNAs last longer or more accessible so they can be translated more often.
Positive regulators can stabilize mRNAs or increase their availability for translation. RNA-binding proteins such as LARP4 bind to mRNAs and enhance their translation, contributing to hypertranslation in tumor-infiltrating T cells. Similarly, KLHL6, a ubiquitin ligase, can influence mRNA translation indirectly by regulating protein stability and signaling pathways that control translation.
Ribosome biogenesis and capacity are upregulated
In simple terms: The cell produces more ribosomes, the machines that make proteins, to increase overall translation capacity.
Increased ribosome biogenesis is a common feature of cells with enhanced cytoplasmic translation. Nutrient signaling through mTOR promotes the synthesis of ribosomal proteins and rRNA, expanding the translational capacity of the cell. This is particularly important in cancer cells, where high rates of protein synthesis support rapid growth [2,4].
Stress-responsive and viral hijacking mechanisms
In simple terms: Under stress or viral infection, cells or viruses can boost translation of specific mRNAs.
Viruses such as alphaviruses and coronaviruses have evolved mechanisms to positively regulate cytoplasmic translation of viral mRNAs while shutting down host translation [3,8]. In cancer, stress granules can sequester translation factors and mRNAs, and their disassembly can release mRNAs for translation, as seen with RIOK1 regulation of PTEN. These examples highlight the context-dependent nature of positive regulation.
Key Genes Involved in GO:2000767 positive regulation of cytoplasmic translation
The following genes and proteins are experimentally implicated in positive regulation of cytoplasmic translation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTOR | Central kinase that promotes translation initiation and ribosome biogenesis in response to nutrients and growth factors | Target for cancer and metabolic studies; key positive regulator |
| LARP4 | RNA-binding protein that mediates hypertranslation in T cells | Drives T cell dysfunction in tumors; immunotherapy target |
| KLHL6 | Ubiquitin ligase that modulates resistance to CD8+ T cell dysfunction | Regulates T cell function and translation-related signaling |
| RIOK1 | Kinase that phase separates to restrict PTEN translation via stress granules | Tumor growth regulation in hepatocellular carcinoma |
| SQLE | Squalene epoxidase involved in cholesterol synthesis; linked to PD-L1 delactylation and liver cancer growth | Metabolic and translation-related cancer biology |
| PD-L1 (CD274) | Immune checkpoint protein whose delactylation promotes nuclear translocation and SQLE transcription | Links immune evasion to metabolic and translational reprogramming |
| EIF4E | Cap-binding protein of the eIF4F complex; rate-limiting for translation initiation | Target for translation inhibition in cancer |
| EIF4G | Scaffold protein of eIF4F; recruits ribosome via eIF3 | Key node in translation initiation regulation |
| EIF4A | RNA helicase in eIF4F; unwinds mRNA secondary structure | Target of translation inhibitors |
| RPS6 | Ribosomal protein S6; phosphorylated by S6K downstream of mTOR | Readout of mTOR-dependent translation activation |
| RPLP0 | P-stalk ribosomal protein; part of the ribosomal stalk | Regulates cytokine-mediated processes and translation |
| RPLP1 | P-stalk ribosomal protein | Involved in translation elongation/termination control |
| RPLP2 | P-stalk ribosomal protein | Master regulator of cytokine-mediated processes |
| PTEN | Tumor suppressor whose translation is restricted by RIOK1 phase separation | Loss promotes tumor growth; translationally regulated |
| CD8A | Marker of cytotoxic T cells; dysfunction linked to KLHL6 and LARP4 [1,5] | Immunotherapy target |
| SQLE | Enzyme in cholesterol synthesis; transcriptionally regulated by PD-L1 | Metabolic reprogramming in liver cancer |
| EIF2A | Alternative initiation factor involved in stress responses | Viral and stress translation regulation |
| NS4A | Alphavirus nonstructural protein that modulates host translation | Viral hijacking of translation |
How Is positive regulation of cytoplasmic translation Regulated?
Positive regulation of cytoplasmic translation is controlled by multiple signaling pathways. The mTOR pathway is a central regulator: it integrates nutrient and growth factor signals to activate translation initiation factors and ribosome biogenesis. The integrated stress response (ISR) can inhibit translation globally while promoting translation of specific mRNAs, and its modulation can lead to positive regulation of certain transcripts. Ribosome-associated factors such as the P-stalk regulate cytokine-mediated processes and can influence translation efficiency. RNA-binding proteins like LARP4 and ubiquitin ligases like KLHL6 provide additional layers of post-transcriptional control [1,5]. In cancer, phase separation of proteins such as RIOK1 can sequester translation machinery into stress granules, dynamically regulating translation. Viral proteins also directly modulate host translation to favor viral mRNA translation [3,8].
positive regulation of cytoplasmic translation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RIOK1 | Hepatocellular carcinoma; stress granule-mediated PTEN translation restriction | Knockout or point-mutation in liver cancer cell lines; xenograft models |
| LARP4 | T cell dysfunction in tumors; hypertranslation | Knockout or overexpression in primary T cells; adoptive transfer models |
| KLHL6 | Resistance to CD8+ T cell dysfunction | Knockout mice or CAR-T cells; tumor challenge models |
| PD-L1 (CD274) | Liver cancer growth; delactylation and SQLE transcription | Knock-in of delactylation-resistant mutants; liver cancer models |
| MTOR | Cancer and metabolic disorders; translation initiation | Conditional knockout or point-mutation; organoid models |
Cancer and tumor growth
Positive regulation of cytoplasmic translation is frequently upregulated in cancer to support rapid proliferation and survival. In hepatocellular carcinoma, RIOK1 phase separation restricts PTEN translation via stress granules, and its dysregulation promotes tumor growth. In liver cancer, PD-L1 delactylation promotes nuclear translocation and elevates SQLE transcription, linking immune checkpoint signaling to metabolic and translational reprogramming. These examples show that positive regulators of translation can be oncogenic drivers or modifiers.
T cell dysfunction and immunotherapy resistance
In the tumor microenvironment, chronic antigen stimulation leads to T cell dysfunction, partly driven by hypertranslation. LARP4-mediated hypertranslation drives T cell dysfunction in tumors, and KLHL6 modulates resistance to CD8+ T cell dysfunction. Targeting positive regulators of cytoplasmic translation may improve T cell-based immunotherapies.
Viral infections
Viruses such as alphaviruses and coronaviruses hijack positive regulation of cytoplasmic translation to synthesize viral proteins efficiently. Alphavirus-infected cells show altered translation regulation, and coronaviruses manipulate host translation machinery. Understanding these mechanisms can inform antiviral strategies.
Metabolic and stress-related disorders
Dysregulated translation is linked to metabolic stress and nutrient sensing. mTOR signaling, which positively regulates translation, is often altered in metabolic disorders. Stress granules and phase-separated compartments can modulate translation under stress, with implications for neurodegeneration and cancer.
From positive regulation of cytoplasmic translation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is gene X required for positive regulation of cytoplasmic translation? | CRISPR knockout cell lines followed by polysome profiling or Ribo-seq |
| Does a specific phosphorylation site on gene X control translation activation? | CRISPR point-mutation knock-in of phospho-dead or phospho-mimetic alleles |
| Does a disease-associated mutation in gene X alter translation? | CRISPR knock-in of the patient mutation; compare translation rates |
| Where does gene X localize during translation activation? | Endogenous tagged knock-in (e.g., GFP or HA) and imaging |
| Does overexpression of gene X increase translation and drive transformation? | Doxycycline-inducible overexpression in cell lines and mouse models |
| Which genes are essential for translation activation in a specific cancer? | Genome-wide CRISPR library screening with Ribo-seq readout |
How to Study the positive regulation of cytoplasmic translation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Genome-wide ribosome occupancy and translation efficiency | Identify mRNAs whose translation is positively regulated [5,6] |
| Polysome profiling | Distribution of mRNAs across polysome fractions | Confirm global translation activation |
| RNA-seq | mRNA abundance | Distinguish transcriptional from translational changes [2,4] |
| Quantitative proteomics | Protein abundance and modifications | Validate translation outputs [2,4] |
| Fluorescent reporter assays | Translation of specific mRNAs in live cells | Monitor 5' UTR-mediated regulation |
| Immunofluorescence | Localization of translation factors and ribosomes | Study stress granules and phase separation |
| CRISPR screens | Essential genes for translation activation | Identify novel positive regulators [1,5] |
Ribosome profiling (Ribo-seq)
Ribo-seq provides a genome-wide snapshot of translating ribosomes at codon resolution. It is the gold standard for measuring changes in translation efficiency and identifying mRNAs whose translation is positively regulated [5,6]. By comparing control and perturbed cells, researchers can pinpoint specific transcripts affected by candidate regulators.
Polysome profiling
Polysome profiling separates mRNAs by the number of ribosomes bound, allowing assessment of global translation activity. It is often used to confirm that a positive regulator increases the fraction of mRNAs in heavy polysomes. This method is complementary to Ribo-seq and can be applied to cells with CRISPR knockouts or overexpression.
RNA-seq and proteomics
RNA-seq measures mRNA abundance, while quantitative proteomics measures protein levels. Combining these with Ribo-seq helps distinguish transcriptional from translational regulation. For example, changes in protein levels without corresponding mRNA changes suggest translational control [2,4].
Imaging and reporter assays
Fluorescent reporters (e.g., GFP) under the control of specific 5' UTRs can monitor translation of individual mRNAs in live cells. Imaging of nascent peptides or tagged ribosomal proteins can reveal spatial and temporal dynamics of translation. These methods are useful for validating findings from high-throughput screens.
How CRISPR Can Be Used to Study GO:2000767 positive regulation of cytoplasmic translation
Knockout
CRISPR knockout is used to delete candidate positive regulators of cytoplasmic translation and assess the impact on global and transcript-specific translation. For example, knocking out LARP4 or KLHL6 can reveal their roles in T cell hypertranslation and dysfunction [1,5]. Knockout cell lines are also valuable for validating hits from CRISPR screens.
Point Mutation
Point mutations can be introduced to study specific residues, such as phosphorylation sites or catalytic residues, that control translation activation. For instance, mutating the kinase domain of RIOK1 or the ubiquitin ligase activity of KLHL6 can dissect their contributions to translation regulation [1,4]. These models help distinguish between scaffolding and enzymatic functions.
Knock-in
Knock-in of disease-associated mutations or tagged alleles allows study of translation regulation in a physiological context. For example, knocking in a delactylation-resistant PD-L1 mutant can test its effect on SQLE transcription and liver cancer growth. Endogenous tagging of translation factors with fluorescent proteins enables live-cell imaging of translation dynamics.
Overexpression
Overexpression of candidate genes can test whether increased dosage is sufficient to drive positive regulation of cytoplasmic translation and downstream phenotypes such as transformation. Inducible overexpression systems allow temporal control. For example, overexpressing LARP4 in T cells can induce hypertranslation and dysfunction.
How EDITGENE Supports positive regulation of cytoplasmic translation Research
Researchers studying positive regulation of cytoplasmic translation-related genes often need to determine whether a candidate gene is causally involved in translation activation, and to dissect the underlying mechanisms. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of cytoplasmic translation research.
Frequently Asked Questions About positive regulation of cytoplasmic translation
What is GO:2000767 positive regulation of cytoplasmic translation?
GO:2000767 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of cytoplasmic translation, the ribosome-dependent synthesis of proteins in the cytoplasm.
What genes are involved in positive regulation of cytoplasmic translation?
Key genes include MTOR, LARP4, KLHL6, RIOK1, and PD-L1 (CD274), as well as translation initiation factors like EIF4E and EIF4G [1,2,4,5,6].
How is cytoplasmic translation positively regulated?
It is positively regulated by signaling pathways such as mTOR, by RNA-binding proteins that enhance mRNA translation, by ribosome-associated factors like the P-stalk, and by viral factors that hijack the machinery [3,6,7,8].
Why is positive regulation of cytoplasmic translation important in cancer?
Cancer cells often upregulate translation to support rapid growth and survival; for example, RIOK1 and PD-L1-mediated mechanisms promote liver cancer growth [2,4].
What methods are used to study positive regulation of cytoplasmic translation?
Common methods include Ribo-seq, polysome profiling, RNA-seq, proteomics, fluorescent reporter assays, and CRISPR screens [1,5,6].
How does mTOR regulate cytoplasmic translation?
mTOR promotes translation initiation by activating eIF4E-binding proteins and S6 kinases, and by stimulating ribosome biogenesis in response to nutrients and growth factors.
What is the role of LARP4 in translation?
LARP4 is an RNA-binding protein that mediates hypertranslation in T cells, contributing to T cell dysfunction in tumors.
Can viruses manipulate positive regulation of cytoplasmic translation?
Yes, alphaviruses and coronaviruses reprogram host translation to favor viral protein synthesis, often by modulating positive regulators [3,8].
What CRISPR models are available to study translation regulation?
Knockout, point-mutation, knock-in, and overexpression models can be generated to test the function of candidate genes in translation [1,4,5].
How does EDITGENE support research on positive regulation of cytoplasmic translation?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, library screening, and bioinformatics services tailored to translation research.
Conclusion
GO:2000767 positive regulation of cytoplasmic translation is a fundamental biological process that controls protein synthesis rates and is implicated in cancer, immune dysfunction, and viral infection. The integration of QuickGO definitions with verified literature highlights key regulators such as MTOR, LARP4, KLHL6, and RIOK1, and underscores the importance of advanced methods like Ribo-seq and CRISPR screening. Understanding this process offers opportunities for therapeutic intervention and for engineering cell models with EDITGENE's CRISPR services.
References
- 1. Cheng H et al.. 2026. The ubiquitin ligase KLHL6 drives resistance to CD8(+) T cell dysfunction.. Nature 651(8105):451-461 PMID: 41535474
- 2. Wang X et al.. 2025. PD-L1 delactylation-promoted nuclear translocation accelerates liver cancer growth through elevating SQLE transcription activity.. Cancer Lett 630:217901 PMID: 40614853
- 3. Carrasco L et al.. 2018. The Regulation of Translation in Alphavirus-Infected Cells.. Viruses 10(2) PMID: 29419763
- 4. Meng F et al.. 2025. RIOK1 phase separation restricts PTEN translation via stress granules activating tumor growth in hepatocellular carcinoma.. Nat Cancer 6(7):1223-1241 PMID: 40467995
- 5. Liu Y et al.. 2025. LARP4-mediated hypertranslation drives T cell dysfunction in tumors.. Nat Immunol 26(9):1488-1500 PMID: 40696044
- 6. Proud CG. 2002. Regulation of mammalian translation factors by nutrients.. Eur J Biochem 269(22):5338-49 PMID: 12423332
- 7. Dopler A et al.. 2024. P-stalk ribosomes act as master regulators of cytokine-mediated processes.. Cell 187(24):6981-6993.e23 PMID: 39437780
- 8. Taguchi F. 2011. [Coronaviruses].. Uirusu 61(2):205-10 PMID: 22916567
